Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: Comparison with conventional structural analyses

Molecular Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 171-176

  Tada, Mitsuhiro ^a   Iggo, Richard D ^b   Waridel, Francois ^b   Nozaki, Michimasa ^a   Matsumoto, Ryoji ^a   Sawamura, Yutaka ^a   Shinohe, Yumiko ^a   Ikeda, Jun ^a   Abe, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Clonal expansion; Malignant astrocytic tumors; p53 mutation; Tumor suppressor genes; Yeast p53 functional assay

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BIOASSAY; CHILD; DNA SEQUENCE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; YEAST;

ADULT; AGED; ALLELES; ARTIFACTS; ASTROCYTOMA; BASE COMPOSITION; BRAIN NEOPLASMS; CHILD; CODON; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENES, P53; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA SPLICING; SACCHAROMYCES CEREVISIAE; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030990910     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199703)18:3<171::AID-MC6>3.0.CO;2-I     Document Type: Article

References (34)

1. Louis DN. The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53:11-21, 1994.
2. Hayashi Y, Yamashita J, Yamaguchi K. Timing and role of p53 mutation in the recurrence of glioma. Biochem Biophys Res Commun 180:1145-1150, 1991.
3. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846-847, 1992.
4. Tada M, Iggo RD, Ishii N, et al. Clonality and stability of the p53 gene in human astrocytic tumor cells: Quantitative analysis of p53 gene mutations by yeast functional assay. Int J Cancer 67:447-450, 1996.
5. Cotton RGH. Current methods of mutation detection. Mutat Res 285:125-144, 1993.
6. Flaman J-M, Frebourg T, Moreau V, et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92:3963-3967, 1995.
7. Friend S. p53: A glimpse at the puppet behind the shadow play. Science 265:334-335, 1994.
8. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System, Springer-Verlag, Berlin, 1993.
9. Waridel F, Estreicher A, Bron L, et al. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene, in press.
10. Ishioka C, Frebourg T, Yan YX, et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5:124-129, 1993.
11. Flaman JM, Frebourg T, Moreau V, et al. A rapid PCR fidelity assay. Nucleic Acids Res 22:3259-3260, 1994.
12. Flaman JM, Waridel F, Estreicher A, et al. The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene 12:813-818, 1996.
13. Rochlitz CF, Heide I, de Kant E, et al. Molecular alterations in a patient with Turcot's syndrome. Br J Cancer 68:519-523, 1993.
14. Zhang S, Feng X, Koga H, Ichikawa T, Abe S, Kumanishi T. p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun 196:851-857, 1993.
15. Chozick BS, Weicker ME, Pezzullo JC, et al. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternative pathways of tumorigenesis. Cancer 73:406-415, 1994.
16. Fujiwara T, Mukhopadhyay T, Cai DW, Morris DK, Roth JA. Retroviral-mediated transduction of p53 gene increases TGFβ expression in a human glioblastoma cell line. Int J Cancer 56:834-839, 1994.
17. Hsieh L-L, Hsia C-F, Wang L-Y, Chen C-J, Ho Y-S. p53 gene mutations in brain tumors in Taiwan. Cancer Lett 78:25-32, 1994.
18. Koga H, Zhang S, Kumanishi T, et al. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single strand conformation polymorphism and immunohistochemistry. Acta Neuropathol 87:225-232, 1994.
19. Kyritsis AP, Bondy ML, Xiao M, et al. Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86:344-349, 1994.
20. Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 9:949-954, 1994.
21. Matsumoto H, Shimura M, Omatsu T, Okaichi K, Majima H, Ohnishi T. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett 87:39-46, 1994.
22. Sarkar FH, Kupsky WJ, Li Y-W, Sreepathi P. Analysis of p53 gene mutation in human gliomas by polymerase chain reaction-based single strand conformation polymorphism and DNA sequencing. Diag Mol Pathol 3:2-8, 1994.
23. Tenan M, Colombo BM, Pollo B, Cajola L, Broggi G, Finocchiaro G. p53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas. Cancer Genet Cytogenet 74:139-143, 1994.
24. Van Meir EG, Kikuchi T, Tada M, et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54:649-652, 1994.
25. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. p53 mutation, expression, and DNA ploidy in evolving gliomas: Evidence for two pathways of progression. J Natl Cancer Inst 86:1011-1017, 1994.
26. Rainov NG, Dobberstein K-U, Fittkau M, et al. Absence of p53 autoantibodies in sera from glioma patients. Clin Cancer Res 1:775-781, 1995.
27. 6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer 75:1339-1342, 1995.
28. Tuszuki T, Tsunoda S, Sakaki T, et al. Studies of retinoblastoma and p53 gene mutations in human astrocytomas. In: Nagai M (ed), Brain Tumor: Research and Therapy, pp. 247-253, Springer Verlag, Tokyo, 1996.
29. Hollstein M, Shomer B, Greenblatt M, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation. Nucleic Acids Res 24:141-146, 1996.
30. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19-26, 1993.
31. Seto E, Usheva A, Zambetti GP, et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028-12032, 1992.
32. Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R, Shenk T. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol 15:227-234, 1995.
33. Maquat LE. When cells stop making sense: Effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1:453-465, 1995.
34. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP. A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245-252, 1988.